Bequests and Planned Gifts ›
What’s New
Research and Patient Care
January 06, 2025
A first-of-it-kind treatment center at Dana-Farber will target RAS, the most commonly mutated oncogene in cancer.
more ›
January 02, 2025
Dana-Farber research shows inherited genetic abnormalities increase the risk of certain pediatric cancers but could also help improve screening and treatment options.
more ›